FINWIRES · TerminalLIVE
FINWIRES

CrowdStrike to Benefit From Higher Cybersecurity Spend, KeyBanc Says

By

CrowdStrike (CRWD) is positioned to benefit from accelerating cybersecurity spending driven by disruption fears stemming from Anthropic's restricted-access advanced Claude Mythos model, KeyBanc said in a Monday research note.

KeyBanc sees CrowdStrike's core runtime protection abilities as the "enduring mission-critical function" for protection against attacks should a Mythos-like model becomes generally available, according to the note.

The company's Falcon platform is well-positioned with many sectors of spending that are likely to be prioritized in expectation of risks posed by Mythos, analysts wrote.

The company is a partner in Anthropic's Project Glasswing designed to test Mythos against cyber threats, which is expected to offer an incremental competitive advantage, KeyBanc stated.

The brokerage said it upgraded the stock to overweight from sector weight and set a price target of $525 per share.

Price: $452.77, Change: $+19.62, Percent Change: +4.53%

Related Articles

Wire

IDP Education to Introduce Malaysia as Study Destination

IDP Education (ASX:IEL) expanded its range of study destinations by supporting students to study in Malaysia, according to a Tuesday statement.The company cited changing student preferences as a reason for the move, with growing demand for new destinations offering strong education quality, career outcomes, and affordable study options.The initial rollout will focus on a select number of markets as part of a phased pilot.IDP Education's shares declined 1% in recent trading on Tuesday.

ASX:IEL
Wire

Infratil Says Moody's Assigns CDC Data Centers 'Baa2' Rating, Stable Outlook

Infratil (NZE:IFT, ASX:IFT) said Moody's Ratings has assigned CDC Data Centers Australia its first public investment grade credit rating of "Baa2" with a stable outlook, according to Tuesday filings with the Australian and New Zealand bourses.The rating reflects CDC's strong financial position, stable long-term contracted revenues, and exceptionally long lease durations averaging 28.4 years, per the filing.The rating will enable CDC to improve access to capital markets, supporting further large-scale infrastructure development driven by rising demand from government, hyperscale cloud providers, and critical industries, the filing added.The company's Kiwi shares shed 1% in recent Tuesday trade.

ASX:IFTNZE:IFT
Wire

Spruce Biosciences Begins Public Offering of Stock, Prefunded Warrants; Shares Fall After Hours

Spruce Biosciences (SPRB) said late Monday it commenced an underwritten public offering of common shares or related prefunded warrants.The company expects to grant underwriters a 30-day option to buy up to 15% more stock at the public offering price, less underwriting discounts and commissions.The offering is subject to market and other conditions, Spruce said.Spruce shares fell 13% in after-hours trading.

$SPRB